Voyager Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results and Participate in Upcoming Investor Confe...
February 18 2021 - 4:01PM
Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene
therapy company focused on developing life-changing treatments for
severe neurological diseases, will report fourth quarter and full
year 2020 financial results after market close on Thursday,
February 25, 2021. Subsequently, at 4:30 p.m. EST, the Company
will host a live conference call and webcast to discuss its
financial results and provide a corporate update.
The conference call may be accessed by dialing (877) 851-3834
for domestic callers, or +1 (631) 291-4595 for international
callers. Please reference conference ID number 3688928 to join the
call. The conference call will be webcast live from the Investors
& Media section of Voyager’s website
at www.voyagertherapeutics.com and will be archived there
following the call for 90 days.
Additionally, the company will participate in a panel discussion
at the Cowen 41st Annual Health Care Conference on Monday, March 1,
2021 at 11:40 a.m. EST.
The webcast session may be accessed from the Investors &
Media section of Voyager’s website
at www.voyagertherapeutics.com. Replays of the webcast will be
archived on the Company's website for at least 30 days.
About Voyager Therapeutics
Voyager Therapeutics is a clinical-stage gene therapy company
focused on developing life-changing treatments for severe
neurological diseases. Voyager is committed to advancing the field
of AAV gene therapy through innovation and investment in vector
engineering and optimization, manufacturing, and dosing and
delivery techniques. Voyager’s wholly owned and partnered pipeline
focuses on severe neurological diseases for which effective new
therapies are needed, including Parkinson’s disease, Huntington’s
disease, Friedreich’s ataxia, and other severe neurological
diseases. For more information on Voyager Therapeutics, please
visit the company’s website at www.voyagertherapeutics.com or
follow @VoyagerTx on Twitter and LinkedIn.
Investors:
Investors@voyagertherapeutics.com
Media:
Sheryl Seapy
W2Opure949-903-4750sseapy@purecommunications.com
Voyager Therapeutics (NASDAQ:VYGR)
Historical Stock Chart
From Apr 2024 to May 2024
Voyager Therapeutics (NASDAQ:VYGR)
Historical Stock Chart
From May 2023 to May 2024